AI startup Anthropic has appointed Vas Narasimhan, the Chief Executive Officer of Novartis, to its board of directors, marking a significant move to strengthen its presence in the healthcare and life sciences domain.
Narasimhan becomes the first executive from the pharmaceutical industry to join Anthropic’s board, highlighting the growing convergence between artificial intelligence and healthcare innovation.
His appointment aligns with Anthropic’s increasing focus on applying AI to areas such as drug discovery, clinical research, and healthcare operations. The company has already been expanding partnerships with major pharmaceutical firms and enhancing its AI capabilities for life sciences applications.
Bringing decades of experience in medicine and global healthcare leadership, Narasimhan has overseen the development and approval of more than 35 novel medicines and vaccines, making him a valuable addition as Anthropic navigates complex, regulated industries.
